Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion D2 Receptor Occupancy and DRD2 Genotype
NCT00846339Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupropion in nicotine dependence, sponsored by Seoul National University Hospital. Started Nov 2008; status: completed.
02
Drugs
bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00846339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00846339.